PCM
ASPN icon

Palisade Capital Management’s Aspen Aerogels ASPN Stock Holding History

Palisade Capital Management’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-49,200
Closed -$221K – 534
2016
Q1 		$221K Buy
+49,200
New +$223K 0.01% 516

Other funds holding ASPN

GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
RO
Reservoir Operations New York $13.2M AUM 10.2% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Palisade Capital Management's ASPN Position: Q2 2016 in Review

Palisade Capital Management sold out of Aspen Aerogels (ASPN) in Q2 2016, closing a stake of 49,200 shares — an estimated $221K sold.

Palisade Capital Management first reported a position in ASPN in Q1 2016 and held it in 1 quarter. The position peaked at $221K in Q1 2016. 58 funds tracked by Wall St. Rank hold ASPN as of Q2 2016.

  • Palisade Capital Management reported no remaining Aspen Aerogels position as of Q2 2016 after selling out during the quarter.
  • Palisade Capital Management sold 49,200 Aspen Aerogels shares in Q2 2016, an estimated $221K.
  • Palisade Capital Management first reported a position in Aspen Aerogels in Q1 2016 and held it in 1 quarter.
  • Palisade Capital Management's Aspen Aerogels position peaked at $221K in Q1 2016.
  • 58 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2016.

Based on Palisade Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.